Health economists estimate it could add approximately $2.76 billion to overall Wegovy sales by 2030, with its share growing from about 3% in 2026 to 17% by 2031
6 GLP-1RAs reduce the appeal of high-calorie foods Increasing evidence suggests GLP-1RA-based medications do more than merely increase satiety but also may reconfigure feeding and preference behaviors in both humans and rodents
Eligible patients can get Wegovy (semaglutide), Zepbound (tirzepatide), or Foundayo (orforglipron) for a $50 copay through December 31, 2027
This small peptide is eliminated by the kidneys and has a plasma half-life of approximately 3 hours, requiring twice-daily subcutaneous injections
The administration of probiotics, specifically Lactobacillus plantarum , Lactcbacillus acidophilus , and Lactobacillus rhamnosus , resulted in an increase